Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Atherectomy System Treats Peripheral Artery Disease

By HospiMedica International staff writers
Posted on 13 Feb 2014
A novel catheter uses a continuous screw to remove diseased material, as it is debulked, facilitating peripheral artery disease (PAD) treatment.

The Phoenix Atherectomy System is a system designed to restore blood flow to the thighs, ankle, and foot by removing soft plaque or calcified lesions in the arteries of PDA patients. More...
The over-the wire system uses a rotating, front-cutting element located at the distal tip of the catheter to shave material directly into the catheter. The shaved material is then continuously captured and eliminated by an internal Archimedes screw running the length of the catheter. The front-cutting design removes need to pass a catheter nosecone beyond a diseased segment before debulking.

Benefits of the system include a cut, capture, and clear mechanism of action, designed to reduce the risk of distal embolization; an over the wire (OTW) catheter design that provides needed pushability and trackability to treat occlusive lesions and navigate tortuous anatomy; and single operator use via the battery operated motor and on/off switch set in the handle, which activates the rotation of the cutting element and Archimedes screw. The Phoenix Atherectomy System is a product of AtheroMed (Menlo Park, CA, USA), and is available in multiple sizes, down to 1.8 mm in diameter with a 5F (1.2 mm) profile.

“The Phoenix Atherectomy System combines a low profile, flexible catheter shaft design with a mechanism of action that continuously clears debris from the body, so physicians can now safely perform atherectomy in vessels that previously may have been out of their reach,” said Mike MacKinnon, President and CEO of AtheroMed. “We are excited to now bring this treatment option to physicians and their patients.”

“Peripheral artery disease, especially lesions located below the knee, can be challenging to treat, even with currently available technologies,” said Thomas Davis, MD, director of the cardiac catheterization lab at St. John Hospital and Medical Center (Detroit, MI, USA). “My experience with the Phoenix device during the EASE clinical study was extremely positive, and I am excited that the device is now available as it will allow me to debulk small vessels that I may not have been able to treat in the past.”

Related Links:

AtheroMed



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.